| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.22 | 4e-05 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.2 | 0.0003 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.098 | 0.002 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.003 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.74 | 0.004 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.005 |